Quantified immune age could transform drug development disease management CytoReason

Quantified ‘immune age’ could transform drug development, disease management: CytoReason

Researchers describe a technique to quantify a personâs âimmune age,â information which could help design and analyze clinical trials â improving the drug development process, among other âimpressiveâ possibilities, says industry expert.

More From BioPortfolio on "Quantified ‘immune age’ could transform drug development, disease management: CytoReason"